Linked Data API

Show Search Form

Search Results

872275
registered interest false more like this
date remove filter
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Medical Treatments more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what discussions he has had with (a) NHS England and (b) NICE on the development of (a) multi-indication pricing, (b) outcomes-based pricing and (c) annuity deals for new treatments. more like this
tabling member constituency Crawley more like this
tabling member printed
Henry Smith remove filter
uin 134189 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-03-29more like thismore than 2018-03-29
answer text <p>The Department has regular and ongoing dialogue with NHS England and the National Institute for Health and Care Excellence on matters related to medicines pricing and patient access to new treatments. We will consider all relevant issues in upcoming discussions with the pharmaceutical industry on medicines pricing arrangements for 2019 onwards to succeed the current Pharmaceutical Price Regulation Scheme.</p> more like this
answering member constituency Winchester more like this
answering member printed Steve Brine more like this
question first answered
less than 2018-03-29T14:02:10.2Zmore like thismore than 2018-03-29T14:02:10.2Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
3960
label Biography information for Henry Smith more like this